Bonus Issues

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE878.55-5.05 (-0.57 %)
PREV CLOSE ( ) 883.60
OPEN PRICE ( ) 875.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 880.00 (97)
VOLUME 4714
TODAY'S LOW / HIGH ( )868.85 891.30
52 WK LOW / HIGH ( )603.95 971
NSE883.001.45 (+0.16 %)
PREV CLOSE( ) 881.55
OPEN PRICE ( ) 881.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 883.00 (6)
VOLUME 67503
TODAY'S LOW / HIGH( ) 869.05 894.00
52 WK LOW / HIGH ( )602 971.9

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.